Non surgical homepathic treatment of kidney stones: A review of north western India
Keywords:
kidney, remedies, health, homeopathy, urinaryAbstract
When treating the vast majority of patients, urolithiasis, also known as nephrolithiasis, is still the main issue that needs to be addressed. Urolithiasis is also known as nephrolithiasis. According to estimates, there are three to four times as many men as women who suffer from this condition. Around the age of 70, the likelihood of developing kidney stones increases to about 12% for men, whereas it is only 5% for women. Diet and environment are just two of the variables that may contribute to kidney stone development. Kidney stones are a serious health issue that affects a lot of developed nations. Right now, the difficult problem that needs to be solved is how to lessen the severe symptoms of acute passage.
Downloads
References
Akinci, M., Esen, T., Koçak, T., et al. (1991). Role of inhibitor deficiency in urolithiasis. I. Rationale ALTERNATIVE & COMPLEMENTARY THERAPIES—FEBRUARY 1998 67 of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations. Eur Urol 19:240-243.
Akram M, Idrees M (2019) Progress and prospects in the management of kidney stones and developments in phytotherapeutic modalities. International Journal of Immunopathology and Pharmacology. 33: 1-5. (https://us.sagepub.com/enus/nam/open-access-at-sage).
Alelign T, Petros B (2018) Kidney stone disease: An update on current concepts. Adv Urol. 2(70): 3068365.
Amarasiri SS, Attanayake AP, Jayatilaka KAPW, Mudduwa LKB (2020) South Asian medicinal plants and chronic kidney disease. Traditional Medicine in Sri Lanka. 5(5):389-412. (doi:10.12032/TMR20200603189).
Bahmani M, Baharvand-Ahmadi B, Tajeddini P, Rafieian-Kopaei M, Naghdi N (2016) Identification of medicinal plants for the treatment of kidney and urinary stones. Journal of Renal Injury Prevention. 5(3):129-133. (DOI: 10.15171/jrip.2016.27).
Bhalerao R, Oberai P, Mehra P, Rai Y, Choubey G, Sahoo AR, et al. (2019). Lycopodium clavatum for the management of urolithiasis: A randomised double blind placebo controlled trial. Indian Journal of Research in Homoeopathy, 13:139-49.
Bhatia S, Sharma S. (2019). To Evaluate TheUsefullness Of Individualised Homoeopathic Medicines Vis-Avis Preidentified Medicines In Management Of Urolithiasis. World Journal of Pharmaceutical Research, 8(7): 2352-2369.
Borden TA, Lyon ES (1969) The effects of magnesium and pH on experimental calcium oxalate stone disease. Invest Urol 6:412–422
Borsatti, A. (1991) Calcium oxalate nephrolithiasis: Defect oxalate transport. Kidney Intl 39:1283-1298.
Brinkley, L., McGuire, J., et al. (1981). Bioavailability of oxalate in foods. Urology 17:534-538
Burnett JC. (2003). The Diseases of Liver. New Delhi: B.Jain Publishers.
Burtis, W.J., Gay, L., Insogna, K.L., et al. (1994) Dietary hypercalciuria in patients with calcium
Butterweck V, Khan SR. (2009). Herbal medicines in the management of urolithiasis: alternative or complementary? Planta Medica. 75(10):1095-1103.
Chakma A. (2015) Renal calculi: Evidence based case study. RA J Appl Res;1:227-34.
Chen YC, Chang CC, Chiu THT Lin MN, Lin CL (2020) The risk of urinary tract infection in vegetarians and non-vegetarians: a prospective study. Scientific Reports. 10:906. (https://doi.org/10.1038/s41598-020-58006-6).
Coe FL, Parks JH (1990) Defenses of an unstable compromise: crystallization inhibitors and the kidney’s role in mineral regulation. Kidney Int 38:625–631
Costa-Bauzá A, Ramis M, Montesinos V, Grases F, Conte A, Pizá P, Pieras E (2007). Type of renal calculi: variation with age and sex. World journal of urology, 1 ;25 (4):415-21.
Curhan, G.C., Willet, W.C., Speizer, F.E., et al. (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126:497-504.
Dawson CJ, Grover PK, Ryall RL (1998) Inter-alpha-inhibitor in urine and calcium oxalate urinary crystals. Br J Urol 81:20–26
Dussol B, Geider S, Lilova A, Leonetti F, Dupuy P, Daudon M, Berland Y, Dagorn JC, Verdier JM (1995) Analysis of the soluble matrix of five morphologically different kidney stones. Urol Res 23:45–51
Eizayaga JE, Pozzi MI, Canan MC, Saravia L. (2016). Prevalence and likelihood ratio of symptoms in patients with good therapeutic response to Lycopodium clavatum. A retrospective study. Homeopathy;105:78-83.
Emil Freundlich, Kamal Saab (1982). Wilhelm Bitterman.Urinary calculi in children. Urology. Aug 20(5): 503-5.
Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ (2007) Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int 72:1503–1511
Fleisch H, Bisaz S (1962) Isolation from urine of pyrophos-phate, a calcification inhibitor. Am J Physiol 203:671–675
Fleisch H, Bisaz S (1964) The inhibitory effect of pyrophos-phate on calcium oxalate precipitation and its relation to uro-lithiasis. Experientia 20:276–277
Fontenelle LF, Sarti TD (2019) Kidney stones: Treatment and prevention. Am Fam Physician. 99(8):490-496.
Gandamayu, I. B. M., Antari, N. W. S., & Strisanti, I. A. S. (2022). The level of community compliance in implementing health protocols to prevent the spread of COVID-19. International Journal of Health & Medical Sciences, 5(2), 177-182. https://doi.org/10.21744/ijhms.v5n2.1897
Ganesan T, Ravi DB, Vasavan J, Khurana A, Nayak D, Periandavan K. Homoeopathic preparation of Berberis vulgaris as an inhibitor of calcium oxalate crystallization: An in vitro evidence. Indian J Res Homeopathy 2015;9:152-7.
Gauri DD, Sanjay BB (2020) Traditional medicinal plants used in treatment of urolithiasis: In Maharashtra region : A review. Bulletin of Environment, Pharmacology and Life Sciences. 9(4):159-170.
Goiko M, Dierolf J, Gleberzon JS, Liao Y, Grohe B, Goldberg HA, de Bruyn JR, Hunter GK (2011) Peptides of Matrix Gla protein inhibit nucleation and growth of hydroxyapatite and calcium oxalate monohydrate crystals. PLoS One 8(11):e80344. doi:10.1371/journal.pone.0080344
Grover PK, Ryall RL (1999) Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity. Eur J Biochem 263:50–56
Gupta AK, Gupta J, Siddiqui VA, Mishra A. (2008) A big urinary calculus expelled with homoeopathic medicine. Indian J Res Homoeopathy 2:50-5.
Hall PM (2009) Nephrolithiasis: Treatment, causes and prevention. Cleve Clin J Med. 76(10):583-91.
Hati AK, Rath S, Nayak C, Raj I, Sahoo AR, Paital B (2018). Successful treatment of ureteric calculi with constitutional homoeopathic medicine Lycopodium clavatum: A Case report. Journal of Drug Delivery and Therapeutics, 15;8(6):1-7.
Heron Silena and Yarnell Eric (1998). Recurrent Kidney Stones. Alternative and Complementary Therapies 4(1):60-67
Hess B, Meinhardt U, Zipperle L, Giovanoli R, Jaeger P (1995) Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: impact of various modifiers. Urol Res 23:231–238
Hess B, Nakagawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99–F106
Hesse A, Siener R, Heynck H, Jahnen A (1993) The influence of dietary factors on the risk of urinary stone formation. Scanning Microsc. 7(3):1119-1127.
Howard JE, Thomas WC, Barker LM, Smith LH, Wadkins CL (1967) The recognition and isolation from urine and serum of a peptide inhibitor to calcification. Johns Hopkins Med J 120:119–136
Hughes, J., Norman, R.W. (1992) Diet and calcium stones. Can Med Assoc J 146:137-143, [review].
Jyothilakshmi V, Thellamudhu G, Kumar A, Khurana A, Nayak D, Kalaiselvi P. (2013) Preliminary investigation on ultra high diluted B. vulgaris in experimental urolithiasis. Homeopath 102:172-8.
Kakitapallia Y, Ampolua J, Madasu SD, Sai Kumar MLS (2020) Detailed review of chronic kidney disease. Kidney Disease. 6:85–91.
Kang HW, Lee SK, Kim WT, Kim YJ, Yun SJ, Lee SC, Kim WJ. (2013) Natural history of asymptomatic renal stones and prediction of stone related events. The Journal of urology. 1;189 5):1740-6.
Kasote DM, Jagtap SD, Thapa D, Khyade MS, Russell WR (2017). Herbal remedies for urinary stones used in India and China: A review. Journal of Ethnopharmacology. 203:55-68. (https://doi.org/10.1016/j.jep.2017.03.038)
Khan F, Haider MF, Singh MK, et al., (2019) A comprehensive review on kidney stones, its diagnosis and treatment with allopathic and Ayurvedic medicines. Urol Nephrol Open Access J. 7(4):69‒74. (DOI: 10.15406/unoaj.2019.07.00247).
Krambeck AE, Lieske JC, Li X, Bergstralh EJ, Melton III LJ, Rule AD (2013). Effect of age on the clinical presentation of incident symptomatic urolithiasis in the general population. The Journal of urology, 189(1):158-64.
Laminski, N.A., Meyers, A.M., et al. (1991). Hyperoxaluria in patients with recurrent calcium oxalate calculi: Dietary and other risk factors. BrJUrol 68:454-458.
Lemann, J., Jr., Piering, W.F., Lennon, E.J. (1969) Possible role of carbohydrate-induced calciuria in calcium oxalate kidney-stone formation. N Engt J Med 280:232-237,1969.
Lohiya A, Kant S, Kapil A, Gupta SK, Misra P, Rai SK (2017). Population-based estimate of urinary stones from Ballabgarh, northern India. The National medical journal of India, 30(4):198
Malabadi RB, Chalannavar RK (2020) Safed musli (Chlorophytum borivilianum): Ethnobotany, phytochemistry and pharmacological updates. Int. J. Curr. Res. Biosci. Plant Biol. 7(11): 25-31.
Malabadi RB, Meti NT, Chalannavar RK (2021) Recent updates on role of herbal medicine for Alzheimer's disease (Dementia). International Journal of Current Research in Biosciences and Plant Biology. 8(1), xxx-xxx. (doi: https://doi.org/10.20546/ijcrbp.2020.801.xxx).
Manjula K, Pazhanichami K, Rajendran K, Kumaran S, Eevera T (2015) Herbal remedy for urinary stones. Vegetables and Human Health. Scientific Publishers (India). 454-468. ISBN: 978-81-7233-901-2.
Mary Elizabeth Dallas (2013). Light Exercise Might Reduce Risk of Kidney Stones Intensity of activity doesn't seem to matter, study finds. WebMD. https://www.webmd.com/kidneystones/news/20131213/light-exercise-might-reduce-risk-of-kidney-stones?print=true. Accessed on December 2019.
Massey, L.K., Roman-Smith, H., Sutton, R.A. (1993) Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calciumoxalate kidney stones. / Am Diet Assoc 93:901-906.
Menon M, Parulkar B, Drach G. (1998) Urinary Lithiasis, Etiology, Diagnosis, and Medical Management., in Campbell’s Urology, Walsh, P.C. (Ed.). 7th Edn. 3:2661-2733. WB Saunders Co.: Philadelphia.
Mente A, D’A. Honey RJ, McLaughlin JR, Bull SB, Logan AG (2007). Ethnic differences in relative risk of idiopathic calcium nephrolithiasis in North America. The Journal of urology, 178(5):1992-7.
Meyer JL, McCall JT, Smith LH (1974) Inhibition of calciumphosphate crystallization by nucleoside phosphates. Calcif Tis-sue Res 15:289–293
Meyer JL, Smith LH (1975) Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol 13:36–39
Muldowney, F.P., Freaney, R., Moloney, M.F. (1982) Importance of dietary sodium in the hypercalciuria syndrome. Kidney Intl 22:292-296.
Nagpal G, Sharma M (2020) Kalanchoe pinnata and its remedial properties to treat kidney stone– A lesser known plant. International Journal of Biology, Pharmacy and allied Sciences. 9(11):3016-3023.
Nakagawa Y, Ahmed MA, Hall SL, Deganello S, Coe FL (1987) Isolation from human calcium oxalate stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. J Clin Invest 79:1782–1787
Niemann T, Kollmann T, Bongartz G. (2008). Diagnostic performance of Low-dose CT for the detection of urolithiasis: A meta-analysis. AJR Am J Roentgenol, 191:396-401.
oxalate kidney stones. Am J Clin Nutr 60:424-429.
Peerapen P, Thongboonkerd V (2018) Caffeine in kidney stone disease: Risk or benefit?. Adv Nutr. 9:419–424. ( doi: https://doi.org/10.1093/advances/nmy016).
Pillay SN, Asplin JR, Coe FL (1998) Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization. Am J Physiol 275:F255–F261
Prasad K, Sujatha D, Bharathi K. (2007) Herbal drugs in urolithiasis-a review. Pharmacognosy Reviews; 1(1):175-179.
Ranabir S, Baruah MP, Devi KR. (2012). Nephrolithiasis: endocrine evaluation. Indian journal of endocrinology and metabolism 16(2):228.
Robertson WG, Peacock M, Nordin BEC (1973) Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 43:31–37
Robertson WG, Scurr DS, Bridge CM (1981) Factors influenc-ing the crystallization of calcium oxalate in urine—a critique. J Crystal Growth 53:182–194
Robertson William G (2017). Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique. Urolithiasis 45, 43–56
Robertson, W., Peacock, M. (1980). The cause of idiopathic calcium stone disease: Hypercalciuria or hyperoxaluria. Nephron 26:105-110,
Ryall RL, Harnett RM, Marshall VR (1981) The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 112:349–356
Sahoo AR, Hati AK, Nayak C, Nayak C. (2019). Treatment of Urinary Stones with Constitutional Homoeopathic Medicines—Two Evidence-Based Case Reports. Homoeopathic Links, 32(01):036-42.
Salman Ahmed, Muhammad Mohtasheemul Hasan, Zafar Alam Mahmood (2016). In vitro urolithiasis models: An evaluation of prophylactic management against kidney stones. Journal of Pharmacognosy and Phytochemistry 5(3): 28-35
Sankar et. al. (2020). Homoeopathic perspective of environmental factors in stone diseases: a mini review. Vol. 23 Issue S6. https://www.researchgate.net/publication/341607481
Seltzer, M.A., Low, R.K., McDonald, M., et al. (1996) Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. / Urol 156:907-909
Shakdvipiya Y, Bhinda A, Chaudhary, A. (2019). Homoeopathic Medicine in the management of Nephrolithiasis: A case series. World Journal of Pharmaceutical Research, 8(2): 761-775.
Shamsuddeen SB, Bano R, Shammari EA, Enezi SH (2013). Risk factors of renal calculi. IOSR Journal of Dental and Medical Sciences, 11(6):90-5.
Shirani M, Arjaki D, Kheiri S, Bijad E, Mohammadi S, Lorigooini Z (2020) An in vitro screening of potential traditional medicinal plants for nephrolithiasis. Clinical Phytoscience. 2-8. (https://doi.org/10.1186/s40816-020-00209-5).
Siddiqui VA., Singh Hari, Gupta Jaya, Nayak C., Singh Vikram, Sinha MN. et. al. (2011). A multicentre observational study to ascertain the role of homoeopathic therapy in Urolithiasis. Indian J Res Homoeopathy, 5(2):30-39.
Siva Rami Reddy E (2017). Effect of homoeopathic medicine Lycopodium clavatum in urinary calculi. IJAR, 3(1):790-1.
Sofia NH, Manickavasakam K, Walter TM (2016). Prevalence and risk factors of kidney stone. Global Journal For Research Analysis, 5(3):183-7.
Sorensen MD, Chi T, Shara NM, Wang H, Hsi RS, Orchard T, Kahn AJ, Jackson RD, Miller J, Reiner AP, Stoller ML (2014). Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women’s Health Initiative. Journal of the American Society of Nephrology, 1;25(2):362-9.
Sumithran PP. A case of multiple urinary calculi. Indian J Res Homoeopathy 2016;10:142-9.
Sundaram SS, Suresh K, Sundaram SP (2019) Traditional knowledge of medicinal plants used to treat kidney related diseases in selected areas of Madurai district, Tamil Nadu, India. Journal of Medicinal Plants Studies. 7(4): 250-253.
Talati J, Tiselius H, Albala DM, Ye Z. Epidemiology of stone diseases in Northern India. In: Urolithiasis: Basic Science and Clinical Practice. London: Springer; 2012. Central Council for Research in Homoeopathy. Dossier: Science of Gentle Healing. New Delhi: Central Council for Research in Homoeopathy; 2018.
Tardivel S, Médétognon J, Randoux C, Kébédé M, Drüeke T, Daudon M, Hennequin C, Lacour B (1999) Alpha-1-microglobulin: inhibitory effect on calcium oxakate crystallization in vitro and decreased urinary excretion in calcium oxalate stone formers. Urol Res 27:243–249
Taylor EN, Curhan GC (2008). Fructose consumption and the risk of kidney stones. Kidney Int. 73(2):207-212.
Taylor EN, Stampfer MJ et al., (2004. Dietary factors and the risk of incident kidney stones in men: New insights after 14 years of follow up. J Am Soc Nephrol. 15(12):3225- 32.
Thongboonkerd V, Chutipongtanate S, Semangoen T, Malasit P (2008) Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation. J Urol 179:1615–1619
Tsuji H, Tohru U, Hirotsugu U, Masanori I, Yuji H, Takashi K (2007) Urinary concentration of osteopontin and association with urinary supersaturation and crystal formation. Int J Urol 14:630–634
Unwin, R. (1996). Unravelling of the molecular mechanisms of kidney stones: Introduction. Lancet 348:1561-1562.
Valentini RP, Lakshmanan Y (2011). Nephrolithiasis in children. Advances in chronic kidney disease, 1;18 (5):370-5.
Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202
Williams CP, Child DF et al., (2001) Why oral calcium supplements may reduce renal stone disease: Report of a clinical pilot study. J Clin Path. 54(1): 54-62.
Worcester EM, Nakagawa Y, Coe FL (1987) Glycoprotein calcium oxalate crystal growth inhibitor in urine. Miner Electrolyte Metab 13:267–272
Worcester EM, Nakagawa Y, Wabner CL, Kumar S, Coe FL (1988) Crystal adsorption and growth slowing by nephrocalcin, albumin and Tamm–Horsfall protein. Am J Physiol 255:F1197–F1205
Yarnell E, Abasca K (2007) Herbs for relieving chronic renal failure. Alternative and Complementary Therapies. (DOI: 10.1089/act.2007.13106).
Yendt ER (1970). Renal calculi. Canadian Medical Association Journal, 102(5):479
Yilmaz E, Batislam E et al., (2008) Citrate levels in fresh tomato juice: A possible dietary alternative to traditional citrate supplementation in stone-forming patients. Urology. 71(3):379-83
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
